tiprankstipranks

Geoffrey Brooke Insider Profile

4 Followers
Geoffrey Brooke, Director at Cynata Therapeutics Limited, holds 1.69M shares in Acrux Limited (Ticker: ARUXF), holds 257.34K shares in Cynata Therapeutics Limited (Ticker: CYYNF).
tipranks
Geoffrey  Brooke

Geoffrey Brooke
Cynata Therapeutics Limited (CYYNF)
Director

Ranked #87,563 out of 98,743 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-34.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$99K
71.49%
28.51%
A breakdown of Geoffrey Brooke's holdings

Insider Roles

Acrux Limited
(ARUXF)
Director
Cynata Therapeutics Limited
(CYYNF)
Director
Roles that Geoffrey Brooke holds in companies

Most Profitable Insider Trade

Stock:
Cynata Therapeutics Limited
(CYYNF)
Rating:Informative Buy
Date:Jun 24, 2020 - Jun 24, 2021
Return:+3.70%
The most profitable trade made by Geoffrey Brooke

Geoffrey Brooke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cynata Therapeutics Limited
Jun 01, 2023
Director
Informative Buy
30.00K
$28.31K
Acrux Limited
Dec 20, 2023
Director
Uninformative Buy
$70.99K
List of latest transactions for each holding click on a transaction to see Geoffrey Brooke's performance on stock

Geoffrey Brooke insider profile FAQ

What is the percentage of profitable transactions made by Geoffrey Brooke?
The percentage of profitable transactions made by Geoffrey Brooke is 20%.
    What is the average return per transaction made by Geoffrey Brooke?
    The average return per transaction made by Geoffrey Brooke is -34.10%.
      What stocks does Geoffrey Brooke hold?
      Geoffrey Brooke holds: CYYNF, ARUXF stocks.
        What was Geoffrey Brooke’s latest transaction?
        Geoffrey Brooke latest transaction was an Uninformative Buy of ―.
          What was Geoffrey Brooke's most profitable transaction?
          Geoffrey Brooke’s most profitable transaction was an Informative Buy of CYYNF stock on June 24, 2020. The return on the trade was 3.70%.
            What is Geoffrey Brooke's role in Cynata Therapeutics Limited?
            Geoffrey Brooke's role in Cynata Therapeutics Limited is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.